Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.160
-0.040 (-1.82%)
Nov 21, 2024, 3:52 PM EST - Market closed

Lexaria Bioscience Ratios and Metrics

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Aug '23 Aug '22 Aug '21 Aug '20 Aug '19 2018 - 2014
Market Capitalization
38818353154
Upgrade
Market Cap Growth
733.96%-51.77%-50.18%13.53%-42.60%-63.99%
Upgrade
Enterprise Value
30510272952
Upgrade
Last Close Price
2.201.052.966.2210.3820.70
Upgrade
PS Ratio
56.1137.5668.9748.9298.93243.74
Upgrade
PB Ratio
3.443.172.312.7112.5521.78
Upgrade
P/TBV Ratio
5.213.292.362.7413.9525.62
Upgrade
EV/Sales Ratio
72.1621.5839.4437.1992.55235.09
Upgrade
Debt / Equity Ratio
0.010.060.010.010.06-
Upgrade
Asset Turnover
0.050.040.020.090.110.09
Upgrade
Inventory Turnover
--2.112.390.810.28
Upgrade
Quick Ratio
55.846.1732.7978.907.208.79
Upgrade
Current Ratio
58.278.2235.9681.188.539.86
Upgrade
Return on Equity (ROE)
-70.66%-130.18%-71.35%-73.16%-166.85%-170.47%
Upgrade
Return on Assets (ROA)
-38.21%-74.81%-39.21%-44.17%-94.23%-97.68%
Upgrade
Return on Capital (ROIC)
-41.33%-77.59%-39.70%-44.99%-101.11%-102.25%
Upgrade
Earnings Yield
-12.63%-78.45%-41.27%-11.39%-12.63%-7.56%
Upgrade
FCF Yield
-12.21%-69.63%-27.98%-11.28%-8.41%-6.73%
Upgrade
Buyback Yield / Dilution
-72.56%-12.38%-34.02%-58.34%-6.95%-9.63%
Upgrade
Total Shareholder Return
-72.56%-12.38%-34.02%-58.34%-6.95%-9.63%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.